Ticagrelor Sustained-release Capsules(Jiangsu Hengrui Medicine)

替格瑞洛缓释胶囊（江苏恒瑞医药）

Report date: 2025/08/18 17:12:04

Base Information

Drug NameTicagrelor Sustained-release Capsules(Jiangsu Hengrui Medicine)
Drug Alias Nameticagrelorum替卡格雷替卡瑞劳替格雷洛替格瑞洛缓释胶囊（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG